z-logo
open-access-imgOpen Access
Proof-of-Concept Trial with the Neurosteroid Pregnenolone Targeting Cognitive and Negative Symptoms in Schizophrenia
Author(s) -
Christine E. Marx,
Richard S.E. Keefe,
Robert Boyer,
Robert M. Hamer,
Jason D. Kilts,
Daniel W. Bradford,
Jennifer Strauss,
Jennifer C. Naylor,
Victoria M. Payne,
Jeffrey A. Lieberman,
Adam Savitz,
Linda A. Leimone,
Lawrence H. Dunn,
Patrizia Porcu,
A. Leslie Morrow,
Lawrence J. Shampine
Publication year - 2009
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/7268-fx30
Subject(s) - pregnenolone , neuroactive steroid , schizophrenia (object oriented programming) , proof of concept , cognition , psychology , neuroscience , clinical psychology , psychotherapist , psychiatry , medicine , computer science , receptor , steroid , hormone , gabaa receptor , operating system

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here